Global Coronavirus Vaccine Market, By Infection Type (SARS-CoV-2, SARS-CoV, MERS-CoV), By Vaccine Type (Virus Vaccine, Viral Vector Vaccine, Nucleic Acid Vaccine, Protein Based Vaccine and Others), By Product Type (Monovalent Vaccine v/s Multivariant Vaccine), By Route of Administration (Intramuscular, Oral, Intranasal), By Patient Type (Adults v/s Pediatric), By End User (Hospitals, Clinics, Research Institutes, Others), By Region, Competition Forecast & Opportunities, 2026

July 2021 | 119 pages | ID: G1B9412D4B78EN
TechSci Research

Abstracts

Global coronavirus vaccine market is expected to grow at a robust rate in value terms to reach USD91325.46 million by the end of 2021. Coronaviruses are a group of viruses belonging to the coronaviridae family that can affect both mammals and birds. The common symptoms include mild illness such as common cold, respiratory tract infections, among others.

The ongoing pandemic novel coronavirus disease (COVID-19) is caused due to SARS-COV-2 and generally spreads from animals to humans and then from humans to humans. The disease usually spreads from the saliva droplets of the infected person or the nose discharges of the infected person when they cough or sneeze. The first case of the disease was reported in December 2019 in Wuhan, China and since then, it has spread to various parts of the world infecting millions. As of 23rd May 2021, coronavirus has affected more than 200 countries with the total number of coronavirus cases reaching 168,032,098 out of which 149,371,973 have recovered and around 3,488,577 people have succumbed to the disease.

Global coronavirus vaccine market is expected to grow at a robust rate during the forecast period. The global coronavirus vaccine market is driven by the increasing prevalence of this disease across different parts of the globe. This has increased the need to protect the world from the virus, thereby increased sales of coronavirus vaccine through 2026. Furthermore, increasing research and development activities by various pharmaceutical & biotechnology players for the development of potential vaccines is anticipated to foster the market growth. According to WHO, there are more than 70 coronavirus vaccines under development by different companies and organizations.

Currently, mRNA-based vaccine named Moderna COVID-19 Vaccine (mRNA-1273), adenovirus-based vaccine named COVID-19 Vaccine AstraZeneca (AZD1222) also known as Covishield in India and Sputnik V which constitutes recombinant adenovirus vaccine which is developed by Gamaleya Research Institute, Russia are being used for vaccination among adults. The vaccine developed by Moderna, Inc., Pfizer Inc., AstraZeneca PLC are leading the race and is currently administered to entire population. T-COVIDTM, AdCOVID and COVI-VAC are intranasal COVID-19 vaccines which are under pre-clinical and phase 1 trials.

The global coronavirus vaccine market is segmented based on infection type, vaccine type, product type, route of administration, patient type, end user, company, and region. Based on infection type, the market can be categorized into SARS-CoV-2, SARS-CoV and MERS-CoV. The SARS-CoV-2 segment is expected to dominate the market since this infection or virus is the primary cause of the pandemic.

Regionally, the global coronavirus vaccine market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these, Asia-Pacific is expected to witness significant growth during the forecast period in the overall coronavirus vaccine market.

Major players operating in the global coronavirus vaccine market include Moderna, Inc., Johnson & Johnson SA, Pfizer Inc., Sinopharm Group Company Ltd., AstraZeneca PLC, are the leading companies and Serum Institute of India Pvt Ltd., Bharat Biotech International Ltd., Sinovac Biotech Ltd., Sanofi SA, GlaxoSmithKline PLC, Novavax, Inc., Airway Therapeutics, Inc., Cadila Healthcare Ltd., CanSino Biologics Inc., Mitsubishi Chemical Holdings Corporation, Eubiologics Co. Ltd., United Biomedical Inc., Merck & Co., Inc., CureVac N.V., Inovio Pharmaceuticals, Inc. among others. The companies are developing advanced technologies and launching new services to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

• Base Year: 2020
• Estimated Year: 2021
• Forecast Period: 2022-2026

Objective of the Study:

• To analyze and estimate the market size of global coronavirus vaccine market from 2021 to 2026.
• To estimate and forecast the market size of global coronavirus vaccine market from 2022 to 2026 and growth rate until 2026.
• To classify and forecast global coronavirus vaccine market based on infection type, vaccine type, product type, route of administration, patient type, end user, company, and regional distribution.
• To identify dominant region or segment in the global coronavirus vaccine market.
• To identify drivers and challenges for global coronavirus vaccine market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global coronavirus vaccine market.
• To conduct pricing analysis for global coronavirus vaccine market.
• To identify and analyze the profile of leading players operating in global coronavirus vaccine market.
• To identify key sustainable strategies adopted by market players in global coronavirus vaccine market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global coronavirus vaccine market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

• Coronavirus vaccine manufacturers, suppliers, distributors, and other stakeholders
• Government bodies such as regulating authorities and policy makers
• Organizations, forums, and alliances related to coronavirus vaccine
• Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global coronavirus vaccine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• Global Coronavirus Vaccine Market, By Infection Type:
• SARS-CoV-2
• SARS-CoV
• MERS-CoV
• Global Coronavirus Vaccine Market, By Vaccine Type:
• Virus Vaccine
• Viral Vector Vaccine
• Nucleic Acid Vaccine
• Protein Based Vaccine
• Others
• Global Coronavirus Vaccine Market, By Product Type:
• Monovalent Vaccine
• Multivariant Vaccine
• Global Coronavirus Vaccine Market, By Route of Administration:
• Intramuscular
• Oral
• Intranasal
• Global Coronavirus Vaccine Market, By Patient Type:
• Adult
• Pediatric
• Global Coronavirus Vaccine Market, By End User:
• Hospitals
• Clinics
• Research Institutes
• Others
• Global Coronavirus Vaccine Market, By Region:
• North America
• United States
• Mexico
• Canada
• Europe
• United Kingdom
• Germany
• France
• Italy
• Spain
• Asia-Pacific
• China
• India
• Singapore
• Japan
• South Korea
• Hong Kong
• Australia
• Thailand
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• UAE
• Saudi Arabia
• Kuwait
• South Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global coronavirus vaccine market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

2. RESEARCH METHODOLOGY

3. IMPACT OF COVID-19 ON GLOBAL CORONAVIRUS VACCINE MARKET

4. EXECUTIVE SUMMARY

5. VOICE OF CUSTOMER

5.1. Brand Awareness
5.2. Vaccine Efficacy
5.3. Patient Satisfaction Analysis
5.4. Post-Vaccination Side Effects

6. GLOBAL CORONAVIRUS VACCINE MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value and By Volume
6.2. Market Share & Forecast
  6.2.1. By Infection Type (SARS-CoV-2, SARS-CoV, MERS-CoV)
  6.2.2. By Vaccine Type (Virus Vaccine, Viral Vector Vaccine, Nucleic Acid Vaccine, Protein Based Vaccine, Others)
  6.2.3. By Product Type (Monovalent Vaccine v/s Multivariant Vaccine)
  6.2.4. By Route of Administration (Intramuscular, Oral, Intranasal)
  6.2.5. By Patient Type (Adult v/s Pediatric)
  6.2.6. By End User (Hospitals, Clinics, Research Institutes, Others)
  6.2.7. By Company (2020)
  6.2.8. By Region
6.3. Market Map

7. NORTH AMERICA CORONAVIRUS VACCINE MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Infection Type
  7.2.2. By Vaccine Type
  7.2.3. By Product Type
  7.2.4. By Route of Administration
  7.2.5. By Patient Type
  7.2.6. By End User
  7.2.7. By Country
7.3. North America: Country Analysis
  7.3.1. United States Coronavirus Vaccine Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Infection Type
      7.3.1.2.2. By Vaccine Type
      7.3.1.2.3. By Product Type
      7.3.1.2.4. By Route of Administration
      7.3.1.2.5. By Patient Type
      7.3.1.2.6. By End User
  7.3.2. Mexico Coronavirus Vaccine Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Infection Type
      7.3.2.2.2. By Vaccine Type
      7.3.2.2.3. By Product Type
      7.3.2.2.4. By Route of Administration
      7.3.2.2.5. By Patient Type
      7.3.2.2.6. By End User
  7.3.3. Canada Coronavirus Vaccine Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Infection Type
      7.3.3.2.2. By Vaccine Type
      7.3.3.2.3. By Product Type
      7.3.3.2.4. By Route of Administration
      7.3.3.2.5. By Patient Type
      7.3.3.2.6. By End User

8. EUROPE CORONAVIRUS VACCINE MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Infection Type
  8.2.2. By Vaccine Type
  8.2.3. By Product Type
  8.2.4. By Route of Administration
  8.2.5. By Patient Type
  8.2.6. By End User
  8.2.7. By Country
8.3. Europe: Country Analysis
  8.3.1. United Kingdom Coronavirus Vaccine Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Infection Type
      8.3.1.2.2. By Vaccine Type
      8.3.1.2.3. By Product Type
      8.3.1.2.4. By Route of Administration
      8.3.1.2.5. By Patient Type
      8.3.1.2.6. By End User
  8.3.2. Germany Coronavirus Vaccine Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Infection Type
      8.3.2.2.2. By Vaccine Type
      8.3.2.2.3. By Product Type
      8.3.2.2.4. By Route of Administration
      8.3.2.2.5. By Patient Type
      8.3.2.2.6. By End User
  8.3.3. France Coronavirus Vaccine Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Infection Type
      8.3.3.2.2. By Vaccine Type
      8.3.3.2.3. By Product Type
      8.3.3.2.4. By Route of Administration
      8.3.3.2.5. By Patient Type
      8.3.3.2.6. By End User
  8.3.4. Italy Coronavirus Vaccine Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Infection Type
      8.3.4.2.2. By Vaccine Type
      8.3.4.2.3. By Product Type
      8.3.4.2.4. By Route of Administration
      8.3.4.2.5. By Patient Type
      8.3.4.2.6. By End User
  8.3.5. Spain Coronavirus Vaccine Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Infection Type
      8.3.5.2.2. By Vaccine Type
      8.3.5.2.3. By Product Type
      8.3.5.2.4. By Route of Administration
      8.3.5.2.5. By Patient Type
      8.3.5.2.6. By End User

9. ASIA-PACIFIC CORONAVIRUS VACCINE MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Infection Type
  9.2.2. By Vaccine Type
  9.2.3. By Product Type
  9.2.4. By Route of Administration
  9.2.5. By Patient Type
  9.2.6. By End User
  9.2.7. By Country
9.3. Asia-Pacific: Country Analysis
  9.3.1. China Coronavirus Vaccine Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Infection Type
      9.3.1.2.2. By Vaccine Type
      9.3.1.2.3. By Product Type
      9.3.1.2.4. By Route of Administration
      9.3.1.2.5. By Patient Type
      9.3.1.2.6. By End User
  9.3.2. India Coronavirus Vaccine Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Infection Type
      9.3.2.2.2. By Vaccine Type
      9.3.2.2.3. By Product Type
      9.3.2.2.4. By Route of Administration
      9.3.2.2.5. By Patient Type
      9.3.2.2.6. By End User
  9.3.3. Singapore Coronavirus Vaccine Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Infection Type
      9.3.3.2.2. By Vaccine Type
      9.3.3.2.3. By Product Type
      9.3.3.2.4. By Route of Administration
      9.3.3.2.5. By Patient Type
      9.3.3.2.6. By End User
  9.3.4. Japan Coronavirus Vaccine Market Outlook
    9.3.4.1. Market Size & Forecast
      9.3.4.1.1. By Value
    9.3.4.2. Market Share & Forecast
      9.3.4.2.1. By Infection Type
      9.3.4.2.2. By Vaccine Type
      9.3.4.2.3. By Product Type
      9.3.4.2.4. By Route of Administration
      9.3.4.2.5. By Patient Type
      9.3.4.2.6. By End User
  9.3.5. South Korea Coronavirus Vaccine Market Outlook
    9.3.5.1. Market Size & Forecast
      9.3.5.1.1. By Value
    9.3.5.2. Market Share & Forecast
      9.3.5.2.1. By Infection Type
      9.3.5.2.2. By Vaccine Type
      9.3.5.2.3. By Product Type
      9.3.5.2.4. By Route of Administration
      9.3.5.2.5. By Patient Type
      9.3.5.2.6. By End User
  9.3.6. Hong Kong Coronavirus Vaccine Market Outlook
    9.3.6.1. Market Size & Forecast
      9.3.6.1.1. By Value
    9.3.6.2. Market Share & Forecast
      9.3.6.2.1. By Infection Type
      9.3.6.2.2. By Vaccine Type
      9.3.6.2.3. By Product Type
      9.3.6.2.4. By Route of Administration
      9.3.6.2.5. By Patient Type
      9.3.6.2.6. By End User
  9.3.7. Australia Coronavirus Vaccine Market Outlook
    9.3.7.1. Market Size & Forecast
      9.3.7.1.1. By Value
    9.3.7.2. Market Share & Forecast
      9.3.7.2.1. By Infection Type
      9.3.7.2.2. By Vaccine Type
      9.3.7.2.3. By Product Type
      9.3.7.2.4. By Route of Administration
      9.3.7.2.5. By Patient Type
      9.3.7.2.6. By End User
  9.3.8. Thailand Coronavirus Vaccine Market Outlook
    9.3.8.1. Market Size & Forecast
      9.3.8.1.1. By Value
    9.3.8.2. Market Share & Forecast
      9.3.8.2.1. By Infection Type
      9.3.8.2.2. By Vaccine Type
      9.3.8.2.3. By Product Type
      9.3.8.2.4. By Route of Administration
      9.3.8.2.5. By Patient Type
      9.3.8.2.6. By End User

10. SOUTH AMERICA CORONAVIRUS VACCINE MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Infection Type
  10.2.2. By Vaccine Type
  10.2.3. By Product Type
  10.2.4. By Route of Administration
  10.2.5. By Patient Type
  10.2.6. By End User
  10.2.7. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Coronavirus Vaccine Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Infection Type
      10.3.1.2.2. By Vaccine Type
      10.3.1.2.3. By Product Type
      10.3.1.2.4. By Route of Administration
      10.3.1.2.5. By Patient Type
      10.3.1.2.6. By End User
  10.3.2. Argentina Coronavirus Vaccine Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Infection Type
      10.3.2.2.2. By Vaccine Type
      10.3.2.2.3. By Product Type
      10.3.2.2.4. By Route of Administration
      10.3.2.2.5. By Patient Type
      10.3.2.2.6. By End User
  10.3.3. Colombia Coronavirus Vaccine Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Infection Type
      10.3.3.2.2. By Vaccine Type
      10.3.3.2.3. By Product Type
      10.3.3.2.4. By Route of Administration
      10.3.3.2.5. By Patient Type
      10.3.3.2.6. By End User

11. MIDDLE EAST AND AFRICA CORONAVIRUS VACCINE MARKET OUTLOOK

11.1. Market Size & Forecast
  11.1.1. By Value
11.2. Market Share & Forecast
  11.2.1. By Infection Type
  11.2.2. By Vaccine Type
  11.2.3. By Product Type
  11.2.4. By Route of Administration
  11.2.5. By Patient Type
  11.2.6. By End User
  11.2.7. By Country
11.3. MEA: Country Analysis
  11.3.1. UAE Coronavirus Vaccine Market Outlook
    11.3.1.1. Market Size & Forecast
      11.3.1.1.1. By Value
    11.3.1.2. Market Share & Forecast
      11.3.1.2.1. By Infection Type
      11.3.1.2.2. By Vaccine Type
      11.3.1.2.3. By Product Type
      11.3.1.2.4. By Route of Administration
      11.3.1.2.5. By Patient Type
      11.3.1.2.6. By End User
  11.3.2. Saudi Arabia Coronavirus Vaccine Market Outlook
    11.3.2.1. Market Size & Forecast
      11.3.2.1.1. By Value
    11.3.2.2. Market Share & Forecast
      11.3.2.2.1. By Infection Type
      11.3.2.2.2. By Vaccine Type
      11.3.2.2.3. By Product Type
      11.3.2.2.4. By Route of Administration
      11.3.2.2.5. By Patient Type
      11.3.2.2.6. By End User
  11.3.3. Kuwait Coronavirus Vaccine Market Outlook
    11.3.3.1. Market Size & Forecast
      11.3.3.1.1. By Value
    11.3.3.2. Market Share & Forecast
      11.3.3.2.1. By Infection Type
      11.3.3.2.2. By Vaccine Type
      11.3.3.2.3. By Product Type
      11.3.3.2.4. By Route of Administration
      11.3.3.2.5. By Patient Type
      11.3.3.2.6. By End User
  11.3.4. South Africa Coronavirus Vaccine Market Outlook
    11.3.4.1. Market Size & Forecast
      11.3.4.1.1. By Value
    11.3.4.2. Market Share & Forecast
      11.3.4.2.1. By Infection Type
      11.3.4.2.2. By Vaccine Type
      11.3.4.2.3. By Product Type
      11.3.4.2.4. By Route of Administration
      11.3.4.2.5. By Patient Type
      11.3.4.2.6. By End User

12. MARKET DYNAMICS

12.1. Drivers
12.2. Challenges

13. MARKET TRENDS & DEVELOPMENTS

14. COMPETITIVE LANDSCAPE

14.1. Competition Outlook
14.2. Company Profiles
  14.2.1. Moderna, Inc.
  14.2.2. Pfizer Inc.
  14.2.3. Johnson & Johnson SA
  14.2.4. Sinopharm Group Company Ltd.
  14.2.5. AstraZeneca PLC
  14.2.6. Serum Institute of India Pvt Ltd.
  14.2.7. Bharat Biotech International Ltd.
  14.2.8. Sinovac Biotech Ltd.
  14.2.9. Sanofi SA
  14.2.10. GlaxoSmithKline PLC
  14.2.11. Novavax, Inc.
  14.2.12. Airway Therapeutics, Inc.
  14.2.13. Cadila Healthcare Ltd.
  14.2.14. CanSino Biologics Inc.
  14.2.15. Mitsubishi Chemical Holdings Corporation
  14.2.16. Eubiologics Co. Ltd.
  14.2.17. United Biomedical Inc.
  14.2.18. Merck & Co., Inc.
  14.2.19. CureVac N.V.
  14.2.20. Inovio Pharmaceuticals, Inc.

15. STRATEGIC RECOMMENDATIONS

16. ABOUT US & DISCLAIMER

List Of Figures

LIST OF FIGURES

Figure 1: Global Coronavirus Vaccine Market Share, By Value (USD Million), 2020-2026F
Figure 2: Global Coronavirus Vaccine Market Share, By Volume (Million Units), 2020-2026F
Figure 3: Global Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 4: Global Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 5: Global Coronavirus Vaccine Market Share, By Product Type, By Value 2020-2026F
Figure 6: Global Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 7: Global Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 8: Global Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 9: Global Coronavirus Vaccine Market Share, Market Map, By Region, By Value, 2020-2026F
Figure 10: North America Coronavirus Vaccine Market Share, By Value (USD Million), 2020-2026F
Figure 11: North America Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 12: North America Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 13: North America Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 14: North America Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 15: North America Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 16: North America Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 17: North America Coronavirus Vaccine Market Share, By Country, By Value, 2020-2026F
Figure 18: United States Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 19: United States Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 20: United States Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 21: United States Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 22: United States Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 23: United States Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 24: Mexico Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 25: Mexico Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 26: Mexico Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 27: Mexico Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 28: Mexico Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 29: Mexico Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 30: Canada Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 31: Canada Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 32: Canada Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 33: Canada Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 34: Canada Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 35: Canada Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 36: Europe Coronavirus Vaccine Market Share, By Value (USD Million), 2020-2026F
Figure 37: Europe Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 38: Europe Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 39: Europe Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 40: Europe Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 41: Europe Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 42: Europe Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 43: Europe Coronavirus Vaccine Market Share, By Country, By Value, 2020-2026F
Figure 44: United Kingdom Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 45: United Kingdom Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 46: United Kingdom Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 47: United Kingdom Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 48: United Kingdom Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 49: United Kingdom Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 50: Germany Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 51: Germany Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 52: Germany Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 53: Germany Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 54: Germany Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 55: Germany Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 56: France Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 57: France Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 58: France Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 59: France Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 60: France Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 61: France Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 62: Italy Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 63: Italy Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 64: Italy Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 65: Italy Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 66: Italy Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 67: Italy Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 68: Spain Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 69: Spain Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 70: Spain Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 71: Spain Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 72: Spain Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 73: Spain Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 74: APAC Coronavirus Vaccine Market Share, By Value (USD Million), 2020-2026F
Figure 75: APAC Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 76: APAC Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 77: APAC Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 78: APAC Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 79: APAC Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 80: APAC Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 81: APAC Coronavirus Vaccine Market Share, By Country, By Value, 2020-2026F
Figure 82: China Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 83: China Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 84: China Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 85: China Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 86: China Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 87: China Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 88: India Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 89: India Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 90: India Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 91: India Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 92: India Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 93: India Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 94: Singapore Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 95: Singapore Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 96: Singapore Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 97: Singapore Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 98: Singapore Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 99: Singapore Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 100: Japan Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 101: Japan Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 102: Japan Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 103: Japan Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 104: Japan Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 105: Japan Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 106: South Korea Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 107: South Korea Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 108: South Korea Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 109: South Korea Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 110: South Korea Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 111: South Korea Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 112: Hong Kong Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 113: Hong Kong Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 114: Hong Kong Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 115: Hong Kong Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 116: Hong Kong Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 117: Hong Kong Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 118: Australia Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 119: Australia Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 120: Australia Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 121: Australia Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 122: Australia Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 123: Australia Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 124: Thailand Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 125: Thailand Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 126: Thailand Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 127: Thailand Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 128: Thailand Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 129: Thailand Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 130: South America Coronavirus Vaccine Market Share, By Value (USD Million), 2020-2026F
Figure 131: South America Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 132: South America Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 133: South America Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 134: South America Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 135: South America Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 136: South America Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 137: South America Coronavirus Vaccine Market Share, By Country, By Value, 2020-2026F
Figure 138: Brazil Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
Figure 139: Brazil Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
Figure 140: Brazil Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
Figure 141: Brazil Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
Figure 142: Brazil Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
Figure 143: Brazil Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
Figure 144: Argentina Coronavirus Vaccine Market Sh